What's new

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Mar 14, 2025 - 15:07
 0
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Pliant, Acelyrin resort to ‘poison pills’ as threat of Concentra buyout looms

Next Article

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID...

Related Posts

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): Bridion, sugammadex, Date of authorisation: 25/07/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0